About Casma Therapeutics

Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomal storage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.

Company Highlights
Year Founded

2018

icon-altEmployees

19

Location (HQ)

USA

Since Last Funding

1 year 10 months

Monthly Website Visitors

1.6K

icon-altTotal Investment Amt

$200M

Last Funding Round

Series C

icon-altMoM Headcount Growth

5.52%

icon-altYoY Headcount Growth

-26.82%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Health Care

Biotechnology

Biotechnology Research

Therapeutics